Acura Pharmaceuticals, Inc
ACUR
Revenue
36.00k
▼-234.00k▼-86.67%
3 Months ChangeAssets
860.00k
▼-546.00k▼-38.83%
3 Months ChangeLiabilities
682.00k
▼-589.00k▼-46.34%
3 Months ChangeFree Cash Flow
1.30M
▲4.31M▲143.07%
36 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-02
Form 8-K
ID: 0001104659-24-105282
2024-07-26
Form 8-K
ID: 0001104659-24-083007
2024-07-02
Form 8-K
ID: 0001104659-24-077294
2024-06-04
Form 8-K
ID: 0001104659-24-068092
2024-05-14
Form 8-K
ID: 0001104659-24-061200
2024-03-26
Form 8-K
ID: 0001104659-24-038925
2024-03-18
Form 8-K
ID: 0001104659-24-035530
2024-02-14
Form 8-K
ID: 0001104659-24-023174
2024-02-02
Form 8-K
ID: 0001104659-24-009817
2024-01-10
Form 8-K
ID: 0001104659-24-003020